GSK, China's Jiangsu Hengrui strike $500 million drug-development deal
The deal comes as GSK focuses on growing its pipeline to offset declining revenues from top drugs and vaccines amid slowing demand and rising competition. It is hoping to reach annual sales of over 40 billion pounds ($53.7 billion) by 2031.
Under the deal, GSK will gain an exclusive licence to Hengrui's HRS-9821, which is being studied as a treatment for chronic obstructive pulmonary disease, with an option for 11 other treatments once they have cleared early-stage trials.
Hengrui said, opens new tab it could earn up to $12 billion in milestone payments if all options are exercised and targets are met under the GSK deal, which would cover therapy areas such as oncology, immunology, and inflammation.
GSK will pay the Chinese firm $500 million upfront.
"This deal reflects our strategic investment in programmes that address validated targets, increasing the likelihood of success, and with the option to advance those assets with the greatest potential for patient impact," GSK Chief Scientific Officer Tony Wood said.
Access to HRS-9821 would support GSK's ambition to treat patients across the widest spectrum of chronic obstructive pulmonary disease, the company said, adding that the drug provides an opportunity for a formulation in the form of a convenient, dry-powder inhaler.
GSK's existing therapies for COPD include antibody treatment Nucala, opens new tab and the Trelegy Ellipta inhaler.
Shanghai-listed shares of Jiangsu Hengrui climbed 6.6% and its Hong Kong-listed stock jumped 8.5%, outperforming the blue-chip CSI 300 Index's (.CSI300), opens new tab 0.1% fall and the Hang Seng Index's (.HIS), opens new tab 0.3% gain.
GSK shares were up 1.5% in London by 0830 GMT, against the 0.2% gain in the wider, blue-chip FTSE 100 (.FTSE), opens new tab index.
($1 = 0.7455 pounds)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
14 minutes ago
- Daily Mail
Rolls-Royce shares take off as jet engine demand soars
Rolls Royce profits soared 50 per cent in the first six months of the year amid growing demand for its jet engines. Shares in the British engineering giant rocketed more than 10 per cent on Thursday morning after Rolls hiked its earnings forecast for the year. The upgrade came after a bumper first-half saw profits hit £1.7billion - compared with £1.1billion a year earlier - and revenue jump 11 per cent from £8.2billion to £9.1billion. Rolls-Royce raised its full-year profit guidance from between £2.7billion to £2.9billion to £3.1billion to £3.2billion. And chief executive Tufan Erginbilgic said the company had overcome supply chain and tariff challenges and is on track to meet its target of profits of up to £3.9billion by 2028. Erginbilgic has been credited with turning the 119-year-old company's fortunes around. Rolls-Royce shares are up more than 85 per cent so far this year and are worth nearly 10 times more than they were when the former BP executive took the reins in 2023. The half-year results gave 'further confidence for mid-term targets', Erginbilgic said, adding that the goal was 'a milestone not a destination' with 'growth prospects beyond the midterm'. Demand for Rolls-Royce's jet engines has been boosted by the recovery of international travel since the pandemic. In the first six months of the year, Erginbilgic said Rolls-Royce had improved the time its engines spend 'on wing' – meaning the hours engines spend powering planes before needing maintenance – and the profitability of its maintenance services. And the company shrugged off the impact of Donald Trump's tariff war, including by taking 'pricing actions where appropriate' and making cost efficiencies. 'By February we were already ready,' Erginbilgic said. 'We didn't know what to predict. In an uncertain world, my personal belief is that a company's job is not to predict what s going to happen but to gear up to respond. 'They need to have the mindset and response capability.' He added: 'Our processes were aligned before tariff numbers hit, we were very quick to go to the mitigations.' Aarin Chiekrie, an equity analyst at Hargreaves Lansdown, said: 'Rolls-Royce continues to soar above expectations, delivering yet another set of high-flying results and profit guidance upgrades. 'The group produces aeroplane engines for larger, long-haul planes. Revenues are being boosted by the upward trend in engine-flying hours, which are now cruising well above pre-pandemic levels.' Chris Beauchamp, chief market analyst at IG, said: 'Rolls-Royce's near tenfold rally since early 2023 reflects strong execution, rising profits and growing cash returns.'
Reuters
14 minutes ago
- Reuters
Hong Kong Q2 GDP expands 3.1%, faster than forecast
HONG KONG, July 31 (Reuters) - Hong Kong's economy grew a faster-than-expected 3.1% year-on-year in the second quarter, official advance estimates showed on Thursday, expanding for a tenth quarter. That was a faster rate than the mean forecast of 2.7% year-on-year growth by 13 economists in a Reuters poll. Hong Kong reported 3.0% economic growth in the first quarter of 2025 and 2.5% growth in the fourth quarter of 2024.
Reuters
14 minutes ago
- Reuters
Exclusive: Top China polysilicon firms plan to shut a third of production capacity, set OPEC-style output quotas, GCL says
BEIJING, July 31 (Reuters) - Chinese producers of polysilicon, a building block for solar panels, are in talks to create a 50 billion yuan ($7 billion) fund to acquire and shut down roughly a third of production capacity and restructure part of the loss-making sector, GCL Technology Holdings ( opens new tab said. The top polysilicon producer told Reuters on Thursday plans were being discussed to acquire and shut at least 1 million metric tons of lower-quality polysilicon capacity. "It is sort of like the OPEC of polysilicon industry, wherein total supply for a specified timeframe has to be agreed by the central committee and production quotas to be allocated to producers," GCL's investor relations director Jun Zhu said. The plan is one of the strongest signals yet that the heightened rhetoric against overcapacity rolled out by the government this month is translating into action. Chinese industry, from solar to electric vehicles, is grappling with massive overcapacity and vicious price wars that are wiping out profits. GCL Chairman Zhu Gongshan said at an industry conference in June that major firms were working to restructure the industry, while local media reported producers were in talks to create an acquisition fund. Reuters is reporting the size, scope and timing of the plan for the first time. State planner the National Development and Reform Commission did not immediately respond to a request for comment. The proposed closures would leave approximately 2 million tons of capacity remaining in the market, Jun Zhu said. China's production capacity was 3.25 million tons at the end of 2024, according to figures from consultancy Bernreuter Research, indicating the proposed closures would comprise some 38% of capacity. President Xi Jinping in early July called for an end to "disorderly price competition," and three days later the industry ministry pledged to calm price wars and retire outdated production capacity during a meeting with solar industry executives. This rhetoric, combined with initiatives from various ministries and provincial governments have sent prices of industrial commodities soaring in recent weeks in anticipation of supply side reforms. Polysilicon prices are up nearly 70%. The platform would be launched in the late third quarter of 2025 and would start making purchases in the fourth quarter, both of excess capacity and of market inventories, Jun Zhu said. The fund's central committee, tasked to "make sure polysilicon prices fluctuate at a price range beneficial to all stakeholders", would be made up of polysilicon producers, platform creditors, and potentially regulators, he said. ($1=7.15 yuan)
